Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Jul;64(7):3157-61.
doi: 10.1128/JVI.64.7.3157-3161.1990.

Proteases from human immunodeficiency virus and avian myeloblastosis virus show distinct specificities in hydrolysis of multidomain protein substrates

A G Tomasselli  1 , J O Hui, T K Sawyer, D J Staples, C A Bannow, I M Reardon, V K Chaudhary, C M Fryling, I Pastan, D J Fitzgerald, et al.
Affiliations

Proteases from human immunodeficiency virus and avian myeloblastosis virus show distinct specificities in hydrolysis of multidomain protein substrates

A G Tomasselli et al. J Virol. 1990 Jul.

Abstract

The virally encoded proteases from human immunodeficiency virus (HIV) and avian myeloblastosis virus (AMV) have been compared relative to their ability to hydrolyze a variant of the three-domain Pseudomonas exotoxin, PE66. This exotoxin derivative, missing domain I and referred to as LysPE40, is made up of a 13-kilodalton NH2-terminal translocation domain II connected by a segment of 40 amino acids to enzyme domain III of the toxin, a 23-kilodalton ADP-ribosyltransferase. HIV protease hydrolyzes two peptide bonds in LysPE40, a Leu-Leu bond in the interdomain region and a Leu-Ala bond in a nonstructured region three residues in from the NH2-terminus. Neither of these sites is cleaved by the AMV enzyme; hydrolysis occurs, instead, at an Asp-Val bond in another part of the interdomain segment and at a Leu-Thr bond in the NH2-terminal region of domain II. Synthetic peptides corresponding to these cleavage sites are hydrolyzed by the individual proteases with the same specificity displayed toward the protein substrate. Peptide substrates for one protease are neither substrates nor competitive inhibitors for the other. A potent inhibitor of HIV type 1 protease was more than 3 orders of magnitude less active toward the AMV enzyme. These results suggest that although the crystallographic models of Rous sarcoma virus protease (an enzyme nearly identical to the AMV enzyme) and HIV type 1 protease show a high degree of similarity, there exist structural differences between these retroviral proteases that are clearly reflected by their kinetic properties.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Science. 1989 Aug 11;245(4918):616-21 - PubMed
    1. Biochemistry. 1990 Jan 9;29(1):264-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1977 Mar;74(3):911-5 - PubMed
    1. Proc Natl Acad Sci U S A. 1984 May;81(9):2645-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1986 Mar;83(5):1320-4 - PubMed

LinkOut - more resources